Transcranial Electromagnetic Treatment (TEMT)

· NeuroEM Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Transcranial Electromagnetic Treatment (TEMT), covering 2020-02-17 to 2020-02-17. Get the full timeline:

Most recent: Clinical Trial Update: Transcranial Electromagnetic Treatment (TEMT) Against Alzheimer's Disease [Phase 1, Phase 2]